Pharmaceutics, Volume 15, Issue 3
2023 March - 316 articles
Cover Story: The delivery of many drugs to the brain is limited by the blood–brain barrier (BBB). Nanoparticle (NP) technologies may be developed to provide targeted drug delivery with controlled release. Polymeric and lipid-based NPs have emerged as versatile and biocompatible materials that provide requisite protection for drugs and improve drug entry to the brain at the BBB. Intranasal drug delivery has been found to bypass the BBB. The details of the pharmacokinetic and pharmacodynamics of drugs associated with drug delivery via intranasal drug-loaded polymeric and lipid-based NPs are emerging from preclinical studies. A combinatory approach of nose-to-brain administration and drug-loaded polymeric and lipid-based NPs is a promising strategy for enhancing drug targeting to the brain. View this paper - Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
- You may sign up for email alerts to receive table of contents of newly released issues.
- PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.